Pediatric genitourinary tumors

Current Opinion in Oncology

Volumn 14, Issue 3, 2002, Pages 273-279

  Merguerian, Paul A ^a   Chang, Barry ^a  

^a CHILDREN S HOSPITAL CENTRAL CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; GENE PRODUCT; IFOSFAMIDE; TISSUE INHIBITOR OF METALLOPROTEINASE; VINCRISTINE;

CANCER CHEMOTHERAPY; CANCER STAGING; CARCINOGENESIS; CHILD; CHILDHOOD CANCER; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CRYPTORCHISM; DRUG EFFICACY; GENE THERAPY; HUMAN; KIDNEY TUMOR; MOLECULAR GENETICS; NEPHRECTOMY; NEPHROBLASTOMA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; REVIEW; RHABDOID TUMOR; RHABDOMYOSARCOMA; TESTIS TUMOR; UROGENITAL TRACT TUMOR; YOLK SAC TUMOR;

CHILD; CLINICAL TRIALS; HUMANS; KIDNEY NEOPLASMS; MALE; RHABDOMYOSARCOMA; TESTICULAR NEOPLASMS; TREATMENT OUTCOME; UROGENITAL NEOPLASMS; WILMS TUMOR;

EID: 0036250829     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-200205000-00004     Document Type: Review

References (43)

1. Clinical spectrum of Denys-Drash and Frasier syndrome
2. Methylation changes in promoter and enhancer regions of the WT1 gene in Wilms' tumors
3. Frequent association of beta-catenin and WT1 mutations in Wilms tumors
4. GDNF expression in Wilms tumor
5. p53 expression in Wilms' tumor: A possible role as prognostic factor
6. Expression of the neurotropin receptor TrkB is associated with unfavorable outcome in Wilms' tumor
7. The survivin:fas ratio in pediatric renal tumors
8. Does nephroblastomatosis influence the natural history and relapse rate in Wilms tumor? a single center experience over 11 years
9. Controversies in the management of Wilms' tumor
10. Bilateral Wilms' tumor: Surgical aspects
11. Intravascular extension of Wilms' tumor
12. Inferior vena cavectomy for nonexcisable Wilms' tumor
13. Vascular control for resection of suprahepatic intracaval Wilms' tumor: Technical considerations
14. Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: Results of the Ninth International Society of Pediatric Oncology Wilms' Tumor trial and study
15. Treatment with nephrectomy only for small, stage I/favorable histology Wilms' tumor: A report from the National Wilms' Tumor Study Group
16. Inhibition of Wilms' tumor growth by intramuscular administration of tissue inhibitor of metalloproteinases-4 plasmid DNA
17. Surgical complications after primary nephrectomy for Wilms' tumor: A report from the National Wilms' tumor study group
18. Congestive heart failure after treatment for Wilms' tumor: A report from the National Wilms' tumor study group
19. Stature loss following treatment for Wilms' tumor
20. Secondary acute myelogenous leukemia in patients previously treated for childhood renal tumors: A report from the National Wilms' tumor study group
21. Pediatric renal masses: Wilms tumor and beyond
22. Clinical presentation of rhabdoid tumors of the kidney
23. Mutations of the p53 gene in malignant rhabdoid tumors of soft tissue and the kidney: Immunohistochemical and DNA direct sequencing analysis
24. Pathologic classification of rhabdomyosarcoma and correlations with molecular studies
25. Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome
26. Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma
27. Detection of the PAX3-FKHR fusion gene in pediatric rhabdomyosarcoma: A reproducible predictor of outcome?
28. Cytogenetic abnormalities in 42 rhabdomyosarcoma: A United Kingdom cancer cytogenetics group study
29. Identification of new genes related to the myogenic differentiation arrest of human rhabdomyosarcoma cells
30. MAGE, BAGE and GAGE gene expression in human rhabdomyosarcomas
31. Whole-body MR imaging for detection of bone metastases in children and young adults: Comparison with skeletal scintigraphy and FDG PET
32. Routine brain imaging is unwarranted in asymptomatic patients with rhabdomyosarcoma arising outside of the head and neck region that is metastatic at diagnosis: A report from the intergroup rhabdomyosarcoma study group
33. Use of reverse transcriptase polymerase chain reaction for diagnosis and staging of alveolar rhabdomyosarcoma, Ewing sarcoma family of tumors, and desmoplastic small round cell tumor
34. A comparison of MyoD1 and fetal acetylcholine receptor expression in childhood tumors and normal tissues: Implications for the molecular diagnosis of minimal disease in rhabdomyosarcomas
35. Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: A selective review of Intergroup Rhabdomyosarcoma Study Group experience and rationale for Intergroup Rhabdomyosarcoma Study V
36. Intergroup rhabdomyosarcoma study-IV: Results for patients with nonmetastatic disease
37. Cyclophosphamide plus topotecan in children with recurrent or refractory solid tumor: A Pediatric Oncology Group phase II study
38. Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: A report from the IRSG
39. Role of high-dose chemotherapy with hematopoietic stem cell rescue in the treatment of metastatic or recurrent rhabdomyosarcoma
40. Cryptorchidism: Aspects of fertility and neoplasms: A study including data of 1,335 consecutive boys who underwent testicular biopsy simultaneously with surgery for cryptorchidism
41. Deletion mapping of 6q21-26 and frequency of 1 p36 deletion in childhood endodermal sinus tumors by microsatellite analysis
42. Controversies in the management of paratesticular rhabdomyosarcoma: Is staging retroperitoneal lymph node dissection necessary for adolescents with resected paratesticular rhabdomyosarcoma?